AARP Hearing Center
Yes, Medicare covers many dementia-related expenses, but coverage for care and treatment vary.
Medicare covers some types of screening and medical care for people with dementia and Alzheimer’s disease. And with restrictions, Medicare also covers several dementia medications and some newer drugs that can help slow the progression of Alzheimer’s.
But as the disease progresses, it doesn’t cover custodial care — the bathing, cleaning, cooking, dressing and walking assistance you may require to live life in the best health and with the most dignity possible.
Dementia refers to several types of neurological conditions that affect the brain and worsen over time. Alzheimer’s disease is the most common form of dementia, representing 60 to 80 percent of cases. But dementia comes in several other forms, too, such as frontotemporal dementia, Lewy body dementia and vascular dementia.
Does Medicare cover Alzheimer’s screening?
Since January 2011, Medicare has covered cognitive assessments as part of its annual Medicare wellness visit, which is a free preventive service not subject to the Part B deductible or coinsurance. During this exam, the doctor assesses your cognitive function through direct observation, discussion and often a memory test.
If your doctor finds anything out of the ordinary during that visit, rest assured that Medicare Part B also covers a separate visit with your regular doctor or specialist to review your cognitive function, confirm a diagnosis and establish a care plan. That secondary visit is subject to the Part B deductible and 20 percent coinsurance.
No single test can determine if a person is living with Alzheimer’s or another form of dementia. Doctors use diagnostic tools combined with medical history and other information — including blood or cerebrospinal fluid tests; brain imaging such as computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) scans; cognitive and functional assessments; and neurological exams — to diagnose Alzheimer’s, according to the Alzheimer’s Association.
Medicare Part B usually covers diagnostic testing, which is subject to a deductible and 20 percent coinsurance. But it may require you to meet additional conditions before it will cover the tests.
For example, a PET scan can help show if beta-amyloid plaques or tau tangles are present in the brain, a marker of Alzheimer’s. Previously, Medicare only covered one brain amyloid PET scan per lifetime for those enrolled in a clinical trial, but the Centers for Medicare & Medicaid Services (CMS) eliminated those limits in October 2023.
This rule change is significant because Medicare requires patients to show evidence of amyloid plaques before covering some of the newer Alzheimer’s medications, such as Leqembi, which received full FDA approval in July 2023.
Medicare also covers care planning with a medical professional for people who have cognitive impairment, a change that started in 2017. Care planning provides Medicare beneficiaries and their caregivers information about medical and nonmedical treatments, clinical trials and support services available within the community.
People who receive proper care planning are shown to have fewer hospitalizations and emergency room visits and better medication management, the Alzheimer’s Association says.
More From AARP
How to Financially Prepare for Alzheimer's
The disease can be financially devastating, but there are ways to ease the burden
Dementia Care: Helping Your Loved One Stay Connected and Safe
Tips for meeting the unique challenges of caring for someone with dementia or Alzheimer's
Test Your Brain Fitness
What a simple battery of tasks can — and cannot — tell about cognition